The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: The Insulin Resistance Atherosclerosis Study (IRAS)

C. C. Lee, Carlos Lorenzo, S. M. Haffner, L. E. Wagenknecht, A. Festa, M. O. Goodarzi, D. Stefanovski, N. C. Olson, J. M. Norris, M. J. Rewers, A. J. Hanley

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Aims/hypothesis: Insulin clearance may decline as an early mechanism compensating for deteriorating insulin sensitivity. However, no previous studies have investigated the association between subclinical inflammation or impaired fibrinolysis and insulin clearance. We examined the association between plasminogen activator inhibitor (PAI)-1, C-reactive protein (CRP), TNF-α, leptin and fibrinogen and the progression of metabolic clearance rate of insulin (MCRI) over time. Methods: We studied 784 non-diabetic white, Hispanic and African-American individuals in the Insulin Resistance Atherosclerosis Study (IRAS). Insulin sensitivity, acute insulin response and MCRI were determined from frequently sampled intravenous glucose tolerance tests at baseline and at 5-year follow-up. Inflammatory and fibrinolytic proteins were measured in fasting plasma at baseline. Results: MCRI had declined significantly by 29% at the 5-year follow-up. We observed a significant association between higher plasma PAI-1 levels and the decline in MCRI in multivariable-adjusted regression models (β = -0.045 [95% CI -0.081, -0.0091]). Higher plasma CRP and leptin levels were associated with a decline in MCRI in unadjusted models, but these associations were non-significant after adjusting for BMI and waist circumference (β = -0.016 [95% CI -0.041, 0.0083] for CRP; β = -0.044 [95% CI -0.10, 0.011] for leptin). A higher plasma TNF-α concentration was associated with a decline in MCRI in unadjusted (β = -0.071 [95% CI -0.14, -0.00087]) but not in multivariable-adjusted (β = -0.056 [95% CI -0.13, 0.017]) models. Plasma fibrinogen level was not associated with the change in MCRI. Conclusions/interpretation: We identified that higher plasma PAI-1 (but not CRP, TNF-α, leptin or fibrinogen) levels independently predicted the progressive decline of insulin clearance in the multiethnic cohort of the IRAS.

Original languageEnglish (US)
Pages (from-to)112-120
Number of pages9
JournalDiabetologia
Volume56
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Metabolic Clearance Rate
Insulin Resistance
Atherosclerosis
Insulin
Proteins
Leptin
C-Reactive Protein
Plasminogen Activator Inhibitor 1
Fibrinogen
Waist Circumference
Fibrinolysis
Glucose Tolerance Test
Hispanic Americans
African Americans
Blood Proteins
Fasting
Inflammation

Keywords

  • C-reactive protein
  • Fibrinogen
  • Leptin
  • Metabolic clearance of insulin
  • Plasminogen activator inhibitor-1
  • TNF-α

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance : The Insulin Resistance Atherosclerosis Study (IRAS). / Lee, C. C.; Lorenzo, Carlos; Haffner, S. M.; Wagenknecht, L. E.; Festa, A.; Goodarzi, M. O.; Stefanovski, D.; Olson, N. C.; Norris, J. M.; Rewers, M. J.; Hanley, A. J.

In: Diabetologia, Vol. 56, No. 1, 01.2013, p. 112-120.

Research output: Contribution to journalArticle

Lee, CC, Lorenzo, C, Haffner, SM, Wagenknecht, LE, Festa, A, Goodarzi, MO, Stefanovski, D, Olson, NC, Norris, JM, Rewers, MJ & Hanley, AJ 2013, 'The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: The Insulin Resistance Atherosclerosis Study (IRAS)', Diabetologia, vol. 56, no. 1, pp. 112-120. https://doi.org/10.1007/s00125-012-2741-8
Lee, C. C. ; Lorenzo, Carlos ; Haffner, S. M. ; Wagenknecht, L. E. ; Festa, A. ; Goodarzi, M. O. ; Stefanovski, D. ; Olson, N. C. ; Norris, J. M. ; Rewers, M. J. ; Hanley, A. J. / The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance : The Insulin Resistance Atherosclerosis Study (IRAS). In: Diabetologia. 2013 ; Vol. 56, No. 1. pp. 112-120.
@article{b59ad509a49d4f00ba797cde145eda03,
title = "The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: The Insulin Resistance Atherosclerosis Study (IRAS)",
abstract = "Aims/hypothesis: Insulin clearance may decline as an early mechanism compensating for deteriorating insulin sensitivity. However, no previous studies have investigated the association between subclinical inflammation or impaired fibrinolysis and insulin clearance. We examined the association between plasminogen activator inhibitor (PAI)-1, C-reactive protein (CRP), TNF-α, leptin and fibrinogen and the progression of metabolic clearance rate of insulin (MCRI) over time. Methods: We studied 784 non-diabetic white, Hispanic and African-American individuals in the Insulin Resistance Atherosclerosis Study (IRAS). Insulin sensitivity, acute insulin response and MCRI were determined from frequently sampled intravenous glucose tolerance tests at baseline and at 5-year follow-up. Inflammatory and fibrinolytic proteins were measured in fasting plasma at baseline. Results: MCRI had declined significantly by 29{\%} at the 5-year follow-up. We observed a significant association between higher plasma PAI-1 levels and the decline in MCRI in multivariable-adjusted regression models (β = -0.045 [95{\%} CI -0.081, -0.0091]). Higher plasma CRP and leptin levels were associated with a decline in MCRI in unadjusted models, but these associations were non-significant after adjusting for BMI and waist circumference (β = -0.016 [95{\%} CI -0.041, 0.0083] for CRP; β = -0.044 [95{\%} CI -0.10, 0.011] for leptin). A higher plasma TNF-α concentration was associated with a decline in MCRI in unadjusted (β = -0.071 [95{\%} CI -0.14, -0.00087]) but not in multivariable-adjusted (β = -0.056 [95{\%} CI -0.13, 0.017]) models. Plasma fibrinogen level was not associated with the change in MCRI. Conclusions/interpretation: We identified that higher plasma PAI-1 (but not CRP, TNF-α, leptin or fibrinogen) levels independently predicted the progressive decline of insulin clearance in the multiethnic cohort of the IRAS.",
keywords = "C-reactive protein, Fibrinogen, Leptin, Metabolic clearance of insulin, Plasminogen activator inhibitor-1, TNF-α",
author = "Lee, {C. C.} and Carlos Lorenzo and Haffner, {S. M.} and Wagenknecht, {L. E.} and A. Festa and Goodarzi, {M. O.} and D. Stefanovski and Olson, {N. C.} and Norris, {J. M.} and Rewers, {M. J.} and Hanley, {A. J.}",
year = "2013",
month = "1",
doi = "10.1007/s00125-012-2741-8",
language = "English (US)",
volume = "56",
pages = "112--120",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance

T2 - The Insulin Resistance Atherosclerosis Study (IRAS)

AU - Lee, C. C.

AU - Lorenzo, Carlos

AU - Haffner, S. M.

AU - Wagenknecht, L. E.

AU - Festa, A.

AU - Goodarzi, M. O.

AU - Stefanovski, D.

AU - Olson, N. C.

AU - Norris, J. M.

AU - Rewers, M. J.

AU - Hanley, A. J.

PY - 2013/1

Y1 - 2013/1

N2 - Aims/hypothesis: Insulin clearance may decline as an early mechanism compensating for deteriorating insulin sensitivity. However, no previous studies have investigated the association between subclinical inflammation or impaired fibrinolysis and insulin clearance. We examined the association between plasminogen activator inhibitor (PAI)-1, C-reactive protein (CRP), TNF-α, leptin and fibrinogen and the progression of metabolic clearance rate of insulin (MCRI) over time. Methods: We studied 784 non-diabetic white, Hispanic and African-American individuals in the Insulin Resistance Atherosclerosis Study (IRAS). Insulin sensitivity, acute insulin response and MCRI were determined from frequently sampled intravenous glucose tolerance tests at baseline and at 5-year follow-up. Inflammatory and fibrinolytic proteins were measured in fasting plasma at baseline. Results: MCRI had declined significantly by 29% at the 5-year follow-up. We observed a significant association between higher plasma PAI-1 levels and the decline in MCRI in multivariable-adjusted regression models (β = -0.045 [95% CI -0.081, -0.0091]). Higher plasma CRP and leptin levels were associated with a decline in MCRI in unadjusted models, but these associations were non-significant after adjusting for BMI and waist circumference (β = -0.016 [95% CI -0.041, 0.0083] for CRP; β = -0.044 [95% CI -0.10, 0.011] for leptin). A higher plasma TNF-α concentration was associated with a decline in MCRI in unadjusted (β = -0.071 [95% CI -0.14, -0.00087]) but not in multivariable-adjusted (β = -0.056 [95% CI -0.13, 0.017]) models. Plasma fibrinogen level was not associated with the change in MCRI. Conclusions/interpretation: We identified that higher plasma PAI-1 (but not CRP, TNF-α, leptin or fibrinogen) levels independently predicted the progressive decline of insulin clearance in the multiethnic cohort of the IRAS.

AB - Aims/hypothesis: Insulin clearance may decline as an early mechanism compensating for deteriorating insulin sensitivity. However, no previous studies have investigated the association between subclinical inflammation or impaired fibrinolysis and insulin clearance. We examined the association between plasminogen activator inhibitor (PAI)-1, C-reactive protein (CRP), TNF-α, leptin and fibrinogen and the progression of metabolic clearance rate of insulin (MCRI) over time. Methods: We studied 784 non-diabetic white, Hispanic and African-American individuals in the Insulin Resistance Atherosclerosis Study (IRAS). Insulin sensitivity, acute insulin response and MCRI were determined from frequently sampled intravenous glucose tolerance tests at baseline and at 5-year follow-up. Inflammatory and fibrinolytic proteins were measured in fasting plasma at baseline. Results: MCRI had declined significantly by 29% at the 5-year follow-up. We observed a significant association between higher plasma PAI-1 levels and the decline in MCRI in multivariable-adjusted regression models (β = -0.045 [95% CI -0.081, -0.0091]). Higher plasma CRP and leptin levels were associated with a decline in MCRI in unadjusted models, but these associations were non-significant after adjusting for BMI and waist circumference (β = -0.016 [95% CI -0.041, 0.0083] for CRP; β = -0.044 [95% CI -0.10, 0.011] for leptin). A higher plasma TNF-α concentration was associated with a decline in MCRI in unadjusted (β = -0.071 [95% CI -0.14, -0.00087]) but not in multivariable-adjusted (β = -0.056 [95% CI -0.13, 0.017]) models. Plasma fibrinogen level was not associated with the change in MCRI. Conclusions/interpretation: We identified that higher plasma PAI-1 (but not CRP, TNF-α, leptin or fibrinogen) levels independently predicted the progressive decline of insulin clearance in the multiethnic cohort of the IRAS.

KW - C-reactive protein

KW - Fibrinogen

KW - Leptin

KW - Metabolic clearance of insulin

KW - Plasminogen activator inhibitor-1

KW - TNF-α

UR - http://www.scopus.com/inward/record.url?scp=84871622464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871622464&partnerID=8YFLogxK

U2 - 10.1007/s00125-012-2741-8

DO - 10.1007/s00125-012-2741-8

M3 - Article

C2 - 23052060

AN - SCOPUS:84871622464

VL - 56

SP - 112

EP - 120

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 1

ER -